Work

Sequential monitoring and characterization of circulating tumor cells (CTCs) using the epic sciences platform in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with recently approved therapeutics.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.4_suppl.78

Authors: Roberta Ferraldeschi, Rachel Krupa, Jessica Louw, Eric Tucker, Natalee Bales, Dena Marrinucci, Penelope Flohr, Ines Figueiredo, David Lorente, Ryan Dittamore, Johann Sebastian De Bono, Gerhardt Attard

Institutions: Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Epic Sciences (United States)

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590734848

Cites:

Cited by: 6

Related to: 10